TITLE

Dysregulation of Peripheral Cytokine Production in Irritable Bowel Syndrome

AUTHOR(S)
Collins, Stephen M.
PUB. DATE
November 2005
SOURCE
American Journal of Gastroenterology;Nov2005, Vol. 100 Issue 11, p2517
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Presents a study on the dysregulation of peripheral cytokine production in irritable bowel syndrome (IBS). Establishment of the link between acute gastroenteritis and the subsequent development of IBS; Evidence of the inflammation in some IBS patients; Demonstration of the changes in the genetic control of cytokines.
ACCESSION #
18613687

 

Related Articles

  • Postinfectious Irritable Bowel Syndrome–A Meta-Analysis. Halvorson, Heather A.; Schlett, Carey D.; Riddle, Mark S. // American Journal of Gastroenterology;Aug2006, Vol. 101 Issue 8, p1894 

    OBJECTIVES: Irritable bowel syndrome (IBS) is a heterogeneous disorder affecting 12% of the population worldwide. Several studies identify IBS as a sequela of infectious gastroenteritis (IGE) with reported prevalence ranging from 4% to 31% and relative risk from 2.5 to 11.9. This meta-analysis...

  • Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Dunlop, Simon P.; Jenkins, David; Spiller, Robin C. // American Journal of Gastroenterology;Jul2003, Vol. 98 Issue 7, p1578 

    : ObjectiveIrritable bowel syndrome after gastroenteritis is well recognized. Our aim was to determine whether postinfective IBS (PI-IBS) has histological or clinical features that are distinct from those of IBS patients with no history of preceding infection.: MethodsA total of 75 consecutive...

  • Post-infectious irritable bowel syndrome. Thabane, Marroon; Marshall, John K. // World Journal of Gastroenterology;8/7/2009, Vol. 15 Issue 29, p3591 

    Post-infectious irritable bowel syndrome (PI-IBS) is a common disorder wherein symptoms of IBS begin after an episode of acute gastroenteritis. Published studies have reported incidence of PI-IBS to range between 5% and 32%. The mechanisms underlying the development of PI-IBS are not fully...

  • Irritable Bowel Syndrome: What it is and what you can do.  // Legal Alert for Supervisors;3/4/2011, Vol. 6 Issue 139, p3 

    The article offers insights on irritable bowel syndrome (IBS) and the ways on how to take care of a person who is suffering from IBS.

  • A Strategy for Management of the Irritable Bowel. Thompson, W. Grant // American Journal of Gastroenterology;Feb1986, Vol. 81 Issue 2, p95 

    Presents research which discussed a medical technique for management of the irritable bowel syndrome. Efficiency of sigmoidoscopy in detecting the disease; Information on drugs used in the treatment of the syndrome; Importance of harmonious physician-patient relationship to the recovery of...

  • Hypothesis Driven Research and Molecular Mechanisms in Functional Dyspepsia: The Beginning of a Beautiful Friendship in Research and Practice? Holtmann, Gerald; Talley, Nicholas J. // American Journal of Gastroenterology;Mar2006, Vol. 101 Issue 3, p593 

    There is accumulating evidence of a genetic predisposition in at least a subset of patients with functional GI symptoms. Hence, hunting for genes in irritable bowel syndrome and functional dyspepsia has become fashionable of late. Unfortunately, as in other fields, replication of gene...

  • Isogel.  // Royal Society of Medicine: Medicines;2002, p309 

    The article presents information on isogel, a proprietary, non-prescription preparation of the (bulking-agent) laxative ispaghula husk. It can be used to treat a number of gastrointestinal disorders, including irritable bowel syndrome, and is available as granules.

  • Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Jiang, X.; Locke III, G. H.; Choung, A. S.; Zinsmeister, A. A.; Schleck, C. D.; Talley, N. J. // Gut;Jun2008, Vol. 57 Issue 6, p756 

    Background: Abdominal bloating and visible distention are common yet poorly understood symptoms. Epidemiological data distinguishing visible distention from bloating are not available. We aimed to evaluate the prevalence and potential risk factors for abdominal bloating and visible distention...

  • The Irritable Bowel Syndrome. Horwitz, Brenda J.; Fisher, Robert S. // New England Journal of Medicine;06/14/2001, Vol. 344 Issue 24, p1846 

    Presents information on irritable bowel syndrome. Epidemiologic features, including altered bowel motility; Diagnosis; Treatment; Value of establishment of trust in doctor-patient relationship.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics